A new study has found that antidepressants in a class known as selective serotonin reuptake inhibitors (SSRIs) could cause reduced bone mass in children. The study, presented at the American Society of Clinical Psychopharmacology 2014 Annual Meeting, found that SSRIs such as Zoloft could reduce the bone mineral density of children, making them more prone to bone injuries and diseases.
The 5-year study is another in a line of recent research cataloguing SSRI side effects among children, including birth defects among children who were born to mothers who used SSRI antidepressants during pregnancy. Doctors in the study said that while the results need to be more carefully analyzed, they are concerning.
Zoloft side effects in children could pose serious medical risks. Children born to women who used Zoloft during pregnancy were found to be at an increased risk of several severe birth defects, including heart defects, brain defects, persistent pulmonary hypertension of the newborn (PPHN), omphalocele and anencephaly.